Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2019, Article ID 6386729, 12 pages
https://doi.org/10.1155/2019/6386729
Research Article

PPAR-γ Activation Exerts an Anti-inflammatory Effect by Suppressing the NLRP3 Inflammasome in Spinal Cord-Derived Neurons

1Department of Orthopedics of Guangzhou Red Cross Hospital, Medical College, Jinan University, Tongfu Road 396, 107, 510120 Guangzhou, China
2Shenzhen Children’s Hospital, Yitian Road 1079, Futian District, 518038 Shenzhen, China
3Department of Intensive Care Unit of Guangzhou Red Cross Hospital, Medical College, Jinan University, Tongfu Road 396, 510120 Guangzhou, China
4Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Yanjiang Road, 107, 510120 Guangzhou, China

Correspondence should be addressed to Hai-Feng Zhang; nc.ude.usys.liam@9fhgnahz and Si-Ming Li; moc.liamtoh@ilmsrd

Received 18 July 2018; Revised 26 December 2018; Accepted 2 February 2019; Published 12 March 2019

Academic Editor: Soh Yamazaki

Copyright © 2019 Qing-Qi Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Massetti and D. M. Stein, “Spinal cord injury,” in Neurocritical Care for the Advanced Practice Clinician, pp. 269–288, Springer, 2018. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Donnelly and P. G. Popovich, “Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury,” Experimental Neurology, vol. 209, no. 2, pp. 378–388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Ahuja, S. Nori, L. Tetreault et al., “Traumatic spinal cord injury—repair and regeneration,” Neurosurgery, vol. 80, no. 3S, pp. S9–S22, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Rust and J. Kaiser, “Insights into the dual role of inflammation after spinal cord injury,” Journal of Neuroscience, vol. 37, no. 18, pp. 4658–4660, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Franchi, T. Eigenbrod, R. Muñoz-Planillo, and G. Nuñez, “The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis,” Nature Immunology, vol. 10, no. 3, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. de Rivero Vaccari, D. Bastien, G. Yurcisin et al., “P2X4 receptors influence inflammasome activation after spinal cord injury,” Journal of Neuroscience, vol. 32, no. 9, pp. 3058–3066, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. K. Mankan, T. Dau, D. Jenne, and V. Hornung, “The NLRP3/ASC/caspase-1 axis regulates IL-1β processing in neutrophils,” European Journal of Immunology, vol. 42, no. 3, pp. 710–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Mortezaee, N. Khanlarkhani, C. Beyer, and A. Zendedel, “Inflammasome: its role in traumatic brain and spinal cord injury,” Journal of Cellular Physiology, vol. 233, no. 7, pp. 5160–5169, 2018. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Zendedel, S. Johann, S. Mehrabi et al., “Activation and regulation of NLRP3 inflammasome by intrathecal application of SDF-1a in a spinal cord injury model,” Molecular Neurobiology, vol. 53, no. 5, pp. 3063–3075, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Tyagi, S. Sharma, P. Gupta, A. S. Saini, and C. Kaushal, “The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases,” Journal of Advanced Pharmaceutical Technology & Research, vol. 2, no. 4, pp. 236–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Jiang, L. Li, B. Liu, Y. Zhang, Q. Chen, and C. Li, “PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats,” Medical Science Monitor, vol. 21, pp. 268–275, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Jain, A. S. Jaggi, and N. Singh, “Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats,” Pharmacological Research, vol. 59, no. 6, pp. 385–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Imielski, J. C. Schwamborn, P. Lüningschrör et al., “Regrowing the adult brain: NF-κB controls functional circuit formation and tissue homeostasis in the dentate gyrus,” PLoS One, vol. 7, no. 2, article e30838, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Y.-W. Fann, Y. A. Lim, Y. L. Cheng et al., “Evidence that NF-κB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke,” Molecular Neurobiology, vol. 55, no. 2, pp. 1082–1096, 2018. View at Publisher · View at Google Scholar · View at Scopus
  16. I. S. Afonina, Z. Zhong, M. Karin, and R. Beyaert, “Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome,” Nature Immunology, vol. 18, no. 8, pp. 861–869, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Wakamatsu, S. Yamamoto, T. Ito et al., “Indoxyl sulfate promotes macrophage IL-1β production by activating aryl hydrocarbon receptor/NF-κ/MAPK cascades, but the NLRP3 inflammasome was not activated,” Toxins, vol. 10, no. 3, p. 124, 2018. View at Publisher · View at Google Scholar · View at Scopus
  18. Q.-Q. Meng, X. J. Liang, P. Wang et al., “Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury,” Neuroscience Letters, vol. 503, no. 3, pp. 191–195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Q.-q. Meng, W. Lei, H. Chen et al., “Combined rosiglitazone and forskolin have neuroprotective effects in SD rats after spinal cord injury,” PPAR Research, vol. 2018, Article ID 3897478, 11 pages, 2018. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Murthy, F. Durco, J. L. Miller-Ocuin et al., “The NLRP3 inflammasome and Bruton’s tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation,” Biochemical and Biophysical Research Communications, vol. 483, no. 1, pp. 230–236, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp, “Thioredoxin-interacting protein links oxidative stress to inflammasome activation,” Nature Immunology, vol. 11, no. 2, pp. 136–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Zhang, J. Xuan, B. B. Zheng et al., “Metformin improves functional recovery after spinal cord injury via autophagy flux stimulation,” Molecular Neurobiology, vol. 54, no. 5, pp. 3327–3341, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Günther, S. Plantman, J. Davidsson, M. Angéria, T. Mathiesen, and M. Risling, “COX-2 regulation and TUNEL-positive cell death differ between genders in the secondary inflammatory response following experimental penetrating focal brain injury in rats,” Acta Neurochirurgica, vol. 157, no. 4, pp. 649–659, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Liu, M. E. Rose, S. Culver, X. Ma, C. E. Dixon, and S. H. Graham, “Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats,” Biochemical and Biophysical Research Communications, vol. 472, no. 4, pp. 648–655, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. J. P. de Rivero Vaccari, G. Lotocki, A. E. Marcillo, W. D. Dietrich, and R. W. Keane, “A molecular platform in neurons regulates inflammation after spinal cord injury,” Journal of Neuroscience, vol. 28, no. 13, pp. 3404–3414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. W.-P. Lin, G. P. Xiong, Q. Lin et al., “Heme oxygenase-1 promotes neuron survival through down-regulation of neuronal NLRP1 expression after spinal cord injury,” Journal of Neuroinflammation, vol. 13, no. 1, p. 52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. F. L. van de Veerdonk, M. G. Netea, C. A. Dinarello, and L. A. B. Joosten, “Inflammasome activation and IL-1β and IL-18 processing during infection,” Trends in Immunology, vol. 32, no. 3, pp. 110–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M.-t. Song, J. Ruan, R. Y. Zhang, J. Deng, Z. Q. Ma, and S. P. Ma, “Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis,” Acta Pharmacologica Sinica, vol. 39, no. 10, pp. 1559–1570, 2018. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Wang, R. Li, X. Wang, Q. Fu, and S. Ma, “Umbelliferone ameliorates cerebral ischemia–reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome,” Neuroscience Letters, vol. 600, pp. 182–187, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Kumar, G. Gupta, K. Anilkumar et al., “15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome,” Scientific Reports, vol. 6, article 31649, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Zhong, A. Umemura, E. Sanchez-Lopez et al., “NF-κB restricts NLRP3 inflammasome activation via p62-dependent mitophagy which eliminates mitochondrial signals,” The Journal of Immunology, vol. 196, Supplement 1, 2016. View at Google Scholar
  32. F. R. Greten, M. C. Arkan, J. Bollrath et al., “NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ,” Cell, vol. 130, no. 5, pp. 918–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Han, W. Cai, L. Mao et al., “Rosiglitazone promotes white matter integrity and long-term functional recovery after focal cerebral ischemia,” Stroke, vol. 46, no. 9, pp. 2628–2636, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. S. P. Patel, D. H. Cox, J. L. Gollihue et al., “Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery,” Experimental Neurology, vol. 293, pp. 74–82, 2017. View at Publisher · View at Google Scholar · View at Scopus